REFERENCES
- Harkess JW. Arthroplasty of hip. In: Canale ST (eds). Campbell's Operative Orthopaedics, 9th edn. St. Louis: Mosby -Year Book 1998: 296–471.
- Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988; 10 (1): 103–110.
- Norden CW, Niederreiter K, Shinners EM. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin. Infection 1986; 14 (3): 136–138.
- Stabile DE, Jacobs AM. Development and application of antibiotic-loaded bone cement beads. J Am Podiatr Med Assoc 1990; 80 (7): 354–359.
- Wahlig H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study. J Bone Joint Surg (Br) 1978; 60-B (2): 270–275.
- Knudsen JD, Fuursted K, Raber S, Espersen F, Frimodt-Moller N. Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrob Agents Chemotherapy 2000; 44 (5): 1247–1254.
- Oztuna V, Ersoz G, Coskun B, Kaya A, Colak M, Kuyurtar F. The effect of the application of foreign body on local and systemic findings of experimental osteomyelitis in mice. Arthroplasty Arthroscopic Surgery 2002; 13 (2): 94–98 (in Turkish). (http://arthroplasty-arthroscopy.mc.metu.edu.tr/2002/no2-6.html, http://arthroplasty-arthroscopy.mc.metu.edu.tr/2002/pdfsno2/voll3no2-6.pdf)
- National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-5th Edition: Approved Standard M7-A5. Villanova, PA: NCCLS 1990
- Monzem M, Garcia-Alvarez F, Laclêriga A, Amorena B. Evaluation of four experimental osteomyelitis infection models by using precolonized implants and bacterial suspensions. Acta Orthop Scand 2002; 73 (1): 11–19.
- Spagnolo N, Greco F, Rossi A, Ciolli L, Teti A, Posteraro P. Chronic staphylococcal osteomyelitis: a new experimental rat model. Infect Immun. 1993; 61 (12): 5225–5230.
- Tunney MM, Ramage G, Patrick S, Nixon JR, Murphy PG, Gorman SP. Antimicrobial susceptibility of bacteria isolated from orthopaedic implants following revision hip surgery. Antimicrob Agents Chemother 1998; 42 (11): 3002–3005.
- Atkins B, Gottlieb T. Fusidic acid in bone and joint infections. Int J Antimicrob Agents 1999; 12 (suppl 2): S79–S93.
- Marone P, Concia E, Andreoni M, Suter F, Cruciani M. Treatment of bone and soft tissue infections with teicoplanin. J Antimicrob Chemother 1990; 25 (3): 435–439.
- South R. Retrospective study of teicoplanin as home continuation of hospital-initiated therapy. Int J Antimicrob Agents 1998; 9 (4): 219–225.
- Yzerman EP, Boelens HA, Vogel M, Verbrugh HA. Efficacy and safety of teicoplanin plus rifampicin in the treat-ment of bacteraemic infections caused by Staphylococcus aureus. J Antimicrob Chemother 1998; 42 (2): 233–239.
- Janknegt R. Teicoplanin in perspective. A critical comparison with vancomycin. Pharm Weekbl Sci 1991; 13 (4): 153–160.
- Schaad HJ, Chuard C, Vaudaux P, Waldvogel FA, Lew DP. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994; 38 (8): 1703–1710.
- Bouza E, Munoz P. Monotherapy versus combination therapy for bacterial infections. Med Clin North Am 2000; 84 (6): 1357–1389.
- Biswas M, Owen K, Jones MK. Hypocalcaemia during fusidic acid therapy. J R Soc Med 2002; 95 (2): 91–93.
- Whitby M. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 1999; 12 (suppl 2): 67–71.
- Fantin B, Leclercq R, Duval J, Carbon C. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37 (11): 2466–2469.
- Turnidge J, Collinon P. Resistance to fusidic acid. Int J Antimicrob Agents 1999; 12 (suppl 2): 35–44.
- Turnidge J. Fusidic acid pharmaology, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 1999; 12 (suppl 2): 23–34.
- Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin Pharmacokinet 1995; 29 (1): 36–45.
- Nijhof MW, Fleer A, Hardus K, et al. Tobramycin-containing bone cement and systemic cefazolin in a one-stage revision. Treatment of infection in a rabbit model. J Biomed Mater Res 2001; 58 (6): 747–53.